By:- Saurav Kasera, Co Founder and CEO, CLIRNET And DocTube

Strategic investment in biopharma and healthcare is a defining step in transforming India into the therapeutic storehouse of the world. By prioritizing innovative solutions for non-communicable diseases, strengthening next-generation training for allied health professionals, and developing global medical tourism hubs, India can build resilient, inclusive healthcare from the grassroots up. This will generate employment, reduce tertiary care burden, drive domestic innovation, and position healthcare as a cornerstone in achieving the government’s vision of capturing 10% of the global services market.

 By:-Dr. Rashida Vapiwala, Founder and CEO, LabelBlind.

The Finance Minister’s focus on emerging technologies such as AI as growth drivers sends a positive and timely message for India’s startup and MSME ecosystem. By placing innovation at the centre of economic growth, the Budget highlights the role of startups in helping MSMEs become globally competitive. The proposed ₹10,000 crore fund for small and medium enterprises is an important step, as it will support high-potential SMEs in scaling operations, adopting new technologies, and building long-term strength, creating the champions of tomorrow. Initiatives like the National Quantum Mission further reflect the government’s long-term approach to strengthening deep-tech capabilities and future-ready infrastructure. As India opens up new trade opportunities through FTAs, AI-led regulatory compliance will be critical for Indian food companies to meet global standards and compete internationally. For LabelBlind, these measures reinforce our commitment to AI-led solutions, innovation, and building scalable platforms that support a resilient and inclusive digital economy.